149 related articles for article (PubMed ID: 26842923)
1. The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.
Tang J; Shi H; Li H; Zhen T; Dong Y; Zhang F; Yang Y; Han A
Tumour Biol; 2016 Aug; 37(8):10287-301. PubMed ID: 26842923
[TBL] [Abstract][Full Text] [Related]
2. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
3. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin.
Liu C; Wang L; Jiang Q; Zhang J; Zhu L; Lin L; Jiang H; Lin D; Xiao Y; Fang W; Guo S
Front Oncol; 2019; 9():211. PubMed ID: 31032220
[No Abstract] [Full Text] [Related]
5. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
6. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
7. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
[TBL] [Abstract][Full Text] [Related]
8. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
9. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
10. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH
Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265
[TBL] [Abstract][Full Text] [Related]
11. Hepatoma-derived growth factor upregulation is correlated with prognostic factors of early-stage cervical adenocarcinoma.
Tsai CC; Huang SC; Tai MH; Chien CC; Huang CC; Hsu YC
Int J Mol Sci; 2014 Nov; 15(11):21492-504. PubMed ID: 25421244
[TBL] [Abstract][Full Text] [Related]
12. Twist1 is essential in maintaining mesenchymal state and tumor-initiating properties in synovial sarcoma.
Lee KW; Lee NK; Ham S; Roh TY; Kim SH
Cancer Lett; 2014 Feb; 343(1):62-73. PubMed ID: 24051309
[TBL] [Abstract][Full Text] [Related]
13. [Curcumin suppresses invasiveness and migration of human glioma cells in vitro by inhibiting HDGF/β-catenin complex].
Luo Q; Luo H; Fu H; Huang H; Huang H; Luo K; Li C; Hu R; Zheng C; Lan C; Tang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Aug; 39(8):911-916. PubMed ID: 31511210
[TBL] [Abstract][Full Text] [Related]
14. [Expressions and significance of E-cadherin and beta-catenin in synovial sarcoma].
Sun BC; Sun Y; Zhao XL; Liu YX; Zhang SW; Liu YX
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):727-30. PubMed ID: 16483482
[TBL] [Abstract][Full Text] [Related]
15. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.
Lin YW; Li CF; Chen HY; Yen CY; Lin LC; Huang CC; Huang HY; Wu PC; Chen CH; Chen SC; Tai MH
Oral Oncol; 2012 Jul; 48(7):629-35. PubMed ID: 22361040
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-939 Directly Targets
Situ J; Zhang H; Jin Z; Li K; Mao Y; Huang W
Onco Targets Ther; 2020; 13():4257-4270. PubMed ID: 32547060
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma.
Saito T; Oda Y; Sakamoto A; Tamiya S; Kinukawa N; Hayashi K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2000 Nov; 192(3):342-50. PubMed ID: 11054718
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas.
Hsu SS; Chen CH; Liu GS; Tai MH; Wang JS; Wu JC; Kung ML; Chan EC; Liu LF
J Neurooncol; 2012 Mar; 107(1):101-9. PubMed ID: 22037800
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma.
Hasegawa T; Yokoyama R; Matsuno Y; Shimoda T; Hirohashi S
Hum Pathol; 2001 Mar; 32(3):257-63. PubMed ID: 11274633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
